Flu vaccine for elderly to be laced with squalene as well as mercury

[Guest guest]

Added comment---Can we take the blinkers off now please? This is not medical mistakes or carelessness---but pre-meditated murder---as in line with the population reduction plan--please--let's get real. Also the staement in the Washington Post article about flu killing 36.000 a year is an out and out fabrication. I believe the figure is closer to an average of 500 or so...http://curezone.com/forums/m.asp?f=374 & i=38 ************************************ E-NEWS FROM THE NATIONAL VACCINE INFORMATION CENTERVienna, Virginia http://www.nvic.org* * * * * * * * * * * * * * * * * * * * * * * UNITED WAY/COMBINED FEDERAL CAMPAIGN #8122* * * * * * * * * * * * * * * * * * * * * * *"Protecting the health and informed consent rights of children since 1982." ==========================================================================================BL Fisher Note: The vaccine adjuvant, MF59, that NIH proposes to add to flu vaccine givento the frail elderly, is not licensed in the U.S. as safe for human use.MF59 contains squalene, which can cause autoimmunity. Some ill Gulf Warveterans, who were given anthrax vaccine and other experimental vaccines,have tested positive for squalene antibodies even though the U.S. Departmentof Defense denies putting the adjuvant MF59 in anthrax and other vaccinesgiven to soldiers.The tragic consequences of experimenting on America's elderly population bygiving them annual flu vaccinations laced with MF59 will be that, when theydevelop lupus, rheumatorid arthritis, asthma or die, it will be written offas old age and unrelated to the squalene injected into their bodies via fluvaccines. The elderly with as yet unidentified genetic factors that makethem exquisitely vulnerable to squalene-induced autommunity or death will bethe first to go down.The suggestion that the notoriously ineffective flu vaccine be made moretoxic by adding squalene to a brew that already contains mercury is nothingmore than a callous disregard for human life. If Americans do not understandwhat is being done to them in the name of disease control and take action,they will be forced one day to be injected with squalene containing fluvaccines whenever the Secretary of Health declares an emergency. Go towww.nvic.org and click on "Liability Shield Given to Pharma" and read NVIC'sletter to Senate staffer Col. Robert Kadlec.http://www.washingtonpost.com/wp-dyn/content/article/2006/04/17/AR2006041700892.htmlThe Washington PostExperts Say Elderly Need Better Flu ShotBy LAURAN NEERGAARD, AP Medical WriterMon Apr 17, 7:13 PMWASHINGTON - Put aside hypothetical worries about bird flu: Regular flualready kills elderly Americans in droves every winter because the vaccinesimply doesn't work as well inside aging bodies as young ones.The National Institutes of Health wants to strengthen flu shots destined forthe elderly, part of a push to get the nation to start treating influenza'syearly attack as seriously as the threat of some super-flu striking in thefuture.The message: Why wait for a pandemic to benefit from better flu vaccines andtreatments?"My great frustration (is) in trying to shake the cage and say, 'We havenot, by any means, optimized how we approach seasonal flu,'" Dr. AnthonyFauci, the NIH's infectious disease chief, told The Associated Press.Topping his do-better list: testing whether higher vaccine doses or addingimmune-boosting compounds to the shots some of the same compounds alreadybeing studied to fight bird flu would improve the elderly's protectionagainst regular winter influenza.In Europe, U.S. flu-shot supplier Chiron Corp. already sells a revved-upversion just for people over age 65. Studies mostly from Italy suggest thatadding a chemical called MF59 to Chiron's regular flu shot spurs a modestlybetter immune response in older people, especially the frail.Chiron wouldn't say if it plans to eventually bring that shot, called Fluad,to the United States; it sells about 20 million doses abroad. Instead,Chiron's U.S. focus has been on testing whether MF59 could improveexperimental vaccines against bird flu.But Fluad is among the approaches catching Fauci's interest as he plans newresearch into improved elder vaccines.Also, at least one well-known vaccine research center, at St. LouisUniversity School of Medicine, is planning a study of higher flu vaccinedoses for the elderly this fall.And NIH recently began recruiting 150 U.S. volunteers to study just whichparts of the immune system change as we age to make flu a more seriousthreat, basic biological underpinnings that remain a mystery despiteinfluenza's unrelenting yearly toll.Here's the sad irony: Influenza kills 36,000 Americans in an average winter,many more during harsh flu seasons and people over age 65 make up 90 percentof those deaths. Yet flu vaccine is less effective in the people who need itmost, protecting roughly 60 percent of elderly recipients compared with 75percent to 90 percent of young healthy people.Just as the body's physical abilities typically slow with age, the immunesystem can become sluggish. It's not impossible to rev it back up. Someearlier research suggests that giving four to six times the normal dose of aflu vaccine component could double the elderly's immune response, says Dr.John Treanor, a University of Rochester vaccine specialist.The question is whether pumped-up vaccines for the elderly would provideenough extra protection to be worth it. Some previous attempts have foundonly slight improvements, and souped-up vaccines cost more to make."Until recently there was a lot of reluctance to do anything that would makethe vaccine more expensive," Treanor says, speculating that cost might be akey reason that Chiron debuted its Fluad shot in Europe.A stronger vaccine might also come with more side effects, cautions Dr.Donald J. Kennedy of St. Louis University.Still, there are low-risk strategies to test. Aside from the simplehigher-dose study his university colleagues are planning, Kennedy wonders ifgiving seniors a flu shot plus a second vaccine the FluMist nasal spray madeof live but weakened flu virus might activate different immune pathways toimprove protection.Ultimately, what may protect the elderly the most is when flu's mainspreaders healthy young people, especially schoolchildren start gettingvaccinated in high-enough numbers to stem the virus' tide.For the first time this fall, all children from age six months to 5 yearswill be recommended for a flu shot. Until now, the government pushedchildhood flu vaccine just for chronically ill youngsters and healthy totsup to age 2.Expect even more children to be on the vaccine list as early as 2007;already under discussion is the 5- to 9-year-old crowd.And with a record 120 million vaccine doses expected this year far more thanthe most ever given, 83 million doses the government is preparing toencourage inoculations for healthy 20-, 30- and 40-somethings this fall,too.EDITOR'S NOTE Lauran Neergaard covers health and medical issues for TheAssociated Press in Washington.«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»Paranormal_Research - Scientific Data & Health Conspiracies Paranormal_ResearchSubscribe:... Paranormal_Research- New Sister Groups: MedicalConspiracies (One Word)Google groups:http://groups.google.comMedicalConspiraciesPost message: MedicalConspiracies (AT) googl (DOT) comSubscribe: MedicalConspiracies- (AT) googl (DOT) com